Platform
Features
0 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Industries
Headquarters
Employees
Links
20 members
8 members
7 members
5 members
2 members
3 members
Alimera Sciences
1 follower
Product School
5 followers
Challenger
3 followers
Seer
4 followers
Allurion
Strada Education Network
CytoReason
VistaGen Therapeutics
Neurelis
2 followers
Formation Bio
ReUp Education
Discover companies